We are currently having growth in genome sequencing as it gets cheaper. Interesting questions are whether or not any of the mutations in this post lead to statistically reduced lifespan once someone has a sample of people who died whose genes have been sequenced, where at least X had this mutation.
We are currently having growth in genome sequencing as it gets cheaper. Interesting questions are whether or not any of the mutations in this post lead to statistically reduced lifespan once someone has a sample of people who died whose genes have been sequenced, where at least X had this mutation.